Skip to main navigation Skip to search Skip to main content

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

*Corresponding author for this work
  • Amsterdam UMC
  • University of Florida
  • University of Texas Medical Branch at Galveston
  • University of Marburg
  • University of Southampton
  • Cornell University

Research output: Contribution to journalArticleAcademicpeer-review

10 Downloads (Pure)

Abstract

The Lassa virus is endemic in parts of West Africa, and it causes hemorrhagic fever with high mortality. The development of a recombinant protein vaccine has been hampered by the instability of soluble Lassa virus glycoprotein complex (GPC) trimers, which disassemble into monomeric subunits after expression. Here, we use two-component protein nanoparticles consisting of trimeric and pentameric subunits to stabilize GPC in a trimeric conformation. These GPC nanoparticles present twenty prefusion GPC trimers on the surface of an icosahedral particle. Cryo-EM studies of GPC nanoparticles demonstrated a well-ordered structure and yielded a high-resolution structure of an unliganded GPC. These nanoparticles induced potent humoral immune responses in rabbits and protective immunity against the lethal Lassa virus challenge in guinea pigs. Additionally, we isolated a neutralizing antibody that mapped to the putative receptor-binding site, revealing a previously undefined site of vulnerability. Collectively, these findings offer potential approaches to vaccine and therapeutic design for the Lassa virus.
Original languageEnglish
Pages (from-to)1759-1772.e12
JournalCell host & microbe
Volume30
Issue number12
Early online date17 Nov 2022
DOIs
Publication statusPublished - 14 Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Lassa virus
  • antibody
  • challenge study
  • cryo-EM
  • nanoparticles
  • vaccine

Fingerprint

Dive into the research topics of 'Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection'. Together they form a unique fingerprint.

Cite this